BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11093436)

  • 1. Activity indices in rheumatoid arthritis.
    Villaverde V; Balsa A; Cantalejo M; Fernández-Prada M; Madero MR; Muñoz-Fernández S; Gijón-Baños J; Martín-Mola E
    J Rheumatol; 2000 Nov; 27(11):2576-81. PubMed ID: 11093436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of disease activity in psoriatic arthritis. Extended report.
    Ujfalussy I; Koó E
    Z Rheumatol; 2003 Feb; 62(1):60-5. PubMed ID: 12624805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
    Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive rheumatoid arthritis.
    Paulus HE; Bulpitt KJ; Ramos B; Park G; Wong WK;
    Arthritis Rheum; 2000 Dec; 43(12):2743-50. PubMed ID: 11145032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why not use OSRA? A comparison of Overall Status in Rheumatoid Arthritis (RA) with ACR core set and other indices of disease activity in RA.
    Birrell FN; Hassell AB; Jones PW; Dawes PT
    J Rheumatol; 1998 Sep; 25(9):1709-15. PubMed ID: 9733450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis.
    Ringold S; Chon Y; Singer NG
    Arthritis Rheum; 2009 Dec; 60(12):3776-83. PubMed ID: 19950286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Paulus HE; Ramos B; Wong WK; Ahmed A; Bulpitt K; Park G; Sterz M; Clements P
    J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assessment of disease activity by patients with rheumatoid arthritis.
    Hanly JG; Mosher D; Sutton E; Weerasinghe S; Theriault D
    J Rheumatol; 1996 Sep; 23(9):1531-8. PubMed ID: 8877920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Disease Activity Score and the EULAR response criteria.
    Fransen J; van Riel PL
    Rheum Dis Clin North Am; 2009 Nov; 35(4):745-57, vii-viii. PubMed ID: 19962619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of single variables and indices to measure disease activity in rheumatoid arthritis.
    van der Heijde DM; van 't Hof M; van Riel PL; van de Putte LB
    J Rheumatol; 1993 Mar; 20(3):538-41. PubMed ID: 8097536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new disease activity index for rheumatoid arthritis: Mean Overall Index for Rheumatoid Arthritis (MOI-RA).
    Mäkinen H; Kautiainen H; Hannonen P; Sokka T
    J Rheumatol; 2008 Aug; 35(8):1522-7. PubMed ID: 18484699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    de Punder YM; Fransen J; Kievit W; Houtman PM; Visser H; van de Laar MA; van Riel PL
    Rheumatology (Oxford); 2012 Sep; 51(9):1610-7. PubMed ID: 22539487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion.
    Vermeer M; Kuper HH; van der Bijl AE; Baan H; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
    Rheumatology (Oxford); 2012 Jun; 51(6):1076-80. PubMed ID: 22302059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.
    Ranzolin A; Brenol JC; Bredemeier M; Guarienti J; Rizzatti M; Feldman D; Xavier RM
    Arthritis Rheum; 2009 Jun; 61(6):794-800. PubMed ID: 19479706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple index to assess disease activity in rheumatoid arthritis.
    Scott DL
    J Rheumatol; 1993 Mar; 20(3):582-4. PubMed ID: 8478879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis.
    Balsa A; Carmona L; González-Alvaro I; Belmonte MA; Tena X; Sanmartí R;
    J Rheumatol; 2004 Jan; 31(1):40-6. PubMed ID: 14705217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
    Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J
    Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.
    Pincus T; Amara I; Koch GG
    Arthritis Rheum; 2005 Apr; 52(4):1031-6. PubMed ID: 15818698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.